Harel Insurance Investments & Financial Services’s UroGen Pharma URGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-82,772	Closed	-$1.65M	–	485
2025 Q3	$1.65M	Sell	82,772 -75,000	-48%	-$1.35M	0.01%	163
2025 Q2	$2.16M	Sell	157,772 -216,210	-58%	-$2.07M	0.02%	144
2025 Q1	$4.14M	Sell	373,982 -89,285	-19%	-$952K	0.05%	123
2024 Q4	$4.93M	Hold	463,267	–	–	0.08%	93
2024 Q3	$5.88M	Sell	463,267 -298	-0.1%	-$4.42K	0.1%	68
2024 Q2	$7.78M	Sell	463,565 -209,922	-31%	-$2.99M	0.15%	66
2024 Q1	$10.1M	Sell	673,487 -196,558	-23%	-$3.21M	0.2%	54
2023 Q4	$13.1M	Sell	870,045 -149	-0%	-$1.93K	0.23%	63
2023 Q3	$12.2M	Sell	870,194 -155,373	-15%	-$2.49M	0.24%	66
2023 Q2	$10.6M	Sell	1,025,567 -301	-0%	-$3.32K	0.26%	49
2023 Q1	$9.48M	Buy	1,025,868 +308	+0%	+$2.83K	0.19%	72
2022 Q4	$9.1M	Sell	1,025,560 -23	-0%	-$218	0.2%	65
2022 Q3	$8.53M	Sell	1,025,583 -28	-0%	-$232	0.21%	77
2022 Q2	$8.4M	Sell	1,025,611 -22	-0%	-$151	0.18%	84
2022 Q1	$8.93M	Sell	1,025,633 -42	-0%	-$328	0.15%	86
2021 Q4	$9.75M	Buy	+1,025,675	New	+$14.5M	0.18%	70
2019 Q3	–	Sell	-3,000	Closed	-$108K	–	573
2019 Q2	$108K	Buy	3,000 +1,000	+50%	+$36.9K	0.01%	238
2019 Q1	$74K	Buy	2,000 +1,000	+100%	+$41.9K	﹤0.01%	238
2018 Q4	$43K	Sell	1,000 -1,600	-62%	-$71.9K	﹤0.01%	311
2018 Q3	$123K	Hold	2,600	–	–	0.01%	253
2018 Q2	$129K	Buy	+2,600	New	+$151K	0.01%	231